Suppr超能文献

慢速冷冻法对人卵母细胞进行冷冻保存的有效性和安全性

The efficacy and safety of human oocyte cryopreservation by slow cooling.

作者信息

Borini Andrea, Coticchio Giovanni

机构信息

Tecnobios Procreazione, Bologna, Italy.

出版信息

Semin Reprod Med. 2009 Nov;27(6):443-9. doi: 10.1055/s-0029-1241053. Epub 2009 Oct 5.

Abstract

Preservation at low temperatures is a practice that has found several applications in medicine and biotechnology. Several types of cells and tissues can be stored virtually indefinitely in liquid nitrogen (-196 degrees C) and returned to physiological temperatures. However, phenomena occurring during cooling and warming may affect the structure and function of the stored material. To some extent, the use of substances with special protective properties, referred to as cryoprotective agents, may avoid this effect, but normally a fraction of the cryopreserved material suffers a partial or total loss of viability. In the context of human in vitro fertilization (IVF), for decades cryopreservation has been used to store different materials of reproductive function, mainly embryos at various developmental stages and spermatozoa. In recent times, the realm of cryopreservation has been expanded to also include fully grown unfertilized oocytes. The storage of oocytes offers obvious advantages, eluding legal and ethical problems that afflict, and sometimes make inapplicable, embryo cryopreservation. Until recently, technical and applicative advances of oocyte cryopreservation were inhibited by the preconception that the unique nature of this cell was an insurmountable obstacle to safe and efficient preservation at low-temperature storage. In fact, through the two alternative methodological approaches of controlled rate slow cooling and vitrification, oocyte cryopreservation has been developed both technically and clinically to a stage that is beginning to challenge the supremacy of embryo freezing as the preferred form of fertility preservation for the treatment of infertile couples. Although several questions remain to be answered as to whether oocyte cryopreservation can ensure adequate standards of efficacy and safety, there appears to be little doubt that in the near future oocyte cryopreservation will be recognized as an established form of IVF treatment.

摘要

低温保存是一种在医学和生物技术领域有多种应用的方法。几种类型的细胞和组织实际上可以无限期地保存在液氮(-196℃)中,并恢复到生理温度。然而,冷却和升温过程中发生的现象可能会影响所保存材料的结构和功能。在一定程度上,使用具有特殊保护特性的物质(称为冷冻保护剂)可以避免这种影响,但通常一部分冷冻保存的材料会部分或全部丧失活力。在人类体外受精(IVF)的背景下,几十年来冷冻保存一直用于储存不同的生殖功能材料,主要是处于不同发育阶段的胚胎和精子。近年来,冷冻保存的领域已扩大到还包括完全成熟的未受精卵母细胞。卵母细胞的储存具有明显优势,避免了困扰胚胎冷冻保存且有时使其无法应用的法律和伦理问题。直到最近,卵母细胞冷冻保存的技术和应用进展受到一种先入之见的抑制,即这种细胞的独特性质是低温安全有效保存的不可逾越的障碍。事实上,通过控制速率缓慢冷却和玻璃化这两种替代方法,卵母细胞冷冻保存在技术和临床方面都已发展到一个阶段,开始挑战胚胎冷冻作为治疗不孕夫妇首选生育保存形式的主导地位。尽管关于卵母细胞冷冻保存能否确保足够的疗效和安全标准仍有几个问题有待解答,但几乎毫无疑问,在不久的将来卵母细胞冷冻保存将被视为一种既定的IVF治疗形式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验